|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5723459A
(en)
|
1991-05-09 |
1998-03-03 |
Vertex Pharmaceuticals Incorporated |
Biologically active acylated amino acid derivatives
|
|
US5844001A
(en)
|
1993-02-26 |
1998-12-01 |
Research Development Foundation |
Combination platinum chemotherapeutic/antiestrogen therapy for human cancers
|
|
FR2757866B1
(fr)
|
1996-12-30 |
2004-12-17 |
Catalyse |
Polymeres comportant des groupes ammoniums quaternaires, leur utilisation pour la fabrication d'un materiau a propretes antibacteriennes et leurs procedes de preparation
|
|
US6403765B1
(en)
|
1998-06-16 |
2002-06-11 |
Thomas Jefferson University |
Truncated Apaf-1 and methods of use thereof
|
|
US6303329B1
(en)
|
1998-07-27 |
2001-10-16 |
Pharmacia & Upjohn Company |
Method for autoactivation of procaspase 8
|
|
US6110691A
(en)
|
2000-01-06 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Activators of caspases
|
|
US6608026B1
(en)
|
2000-08-23 |
2003-08-19 |
Board Of Regents, The University Of Texas System |
Apoptotic compounds
|
|
AU2002211602A1
(en)
|
2000-10-11 |
2002-04-22 |
Johns Hopkins University |
Polymer controlled delivery of a therapeutic agent
|
|
WO2002048329A2
(en)
|
2000-11-20 |
2002-06-20 |
Idun Pharmaceuticals, Inc. |
Membrane derived caspase-3, compositions comprising the same and methods of use therefor
|
|
US6878743B2
(en)
|
2001-09-18 |
2005-04-12 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
WO2004066958A2
(en)
|
2003-01-30 |
2004-08-12 |
The Trustees Of Princeton University |
Caspase-9:bir3 domain of xiap complexes and methods of use
|
|
US7632972B2
(en)
|
2003-10-30 |
2009-12-15 |
The Board Of Trustees Of The University Of Illionis |
Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells
|
|
BRPI0417498A
(pt)
|
2003-12-09 |
2007-05-29 |
Us Gov Health & Human Serv |
método para suprimir uma resposta imune em um indivìduo; método de inibição da proliferação de um célula; método de tratamento de um distúrbio proliferativo em um indivìduo; método para selecionar um agente imunossupressor ou anti-proliferativo; composição farmacêutica e estente vascular
|
|
US8440610B2
(en)
|
2004-11-12 |
2013-05-14 |
Massachusetts Institute Of Technology |
Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells
|
|
WO2008134474A2
(en)
|
2007-04-27 |
2008-11-06 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods including cell death inducers and procaspase activation
|
|
US20070049602A1
(en)
|
2005-05-26 |
2007-03-01 |
The Board Of Trustees Of The University Of Illinois |
Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3
|
|
CN101184491A
(zh)
|
2005-05-26 |
2008-05-21 |
伊利诺伊大学评议会 |
包括活化半胱天冬酶-3酶原的癌细胞内选择性细胞凋亡诱导
|
|
RU2408584C2
(ru)
|
2005-06-23 |
2011-01-10 |
Мерк Шарп Энд Домэ Корп. |
Ингибиторы тирозинкиназы
|
|
ES2580108T3
(es)
|
2005-07-11 |
2016-08-19 |
Aerie Pharmaceuticals, Inc |
Compuestos de isoquinolina
|
|
TWI373473B
(en)
|
2005-09-02 |
2012-10-01 |
Otsuka Pharma Co Ltd |
Anticancer agent
|
|
WO2007033374A2
(en)
|
2005-09-16 |
2007-03-22 |
Schering Corporation |
Pharmaceutical compositions and methods using temozolomide and a protein kinase inhibitor
|
|
US20070111936A1
(en)
|
2005-11-15 |
2007-05-17 |
Vladimir Pak |
Complex of alpha-fetoprotein and inducers of apoptosis for the treatment of cancer
|
|
CA2651395A1
(en)
|
2006-05-19 |
2007-11-29 |
Board Of Trustees Of The University Of Illinois |
Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明(cyclopamine)類似物類
|
|
EA018503B1
(ru)
|
2007-07-20 |
2013-08-30 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Замещенные производные индазола, активные как ингибиторы киназы
|
|
RU2360692C1
(ru)
|
2007-12-21 |
2009-07-10 |
Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) |
Средство, стимулирующее апоптоз клеток лейкемии человека
|
|
BRPI0907162A2
(pt)
|
2008-01-11 |
2015-07-07 |
Univ California |
Composto, composição farmacêutica e métodos para ativar procaspase executora 3, 6 e/ou 7 e para tratar um estado de doença em um mamífero
|
|
US20100291214A1
(en)
|
2008-12-23 |
2010-11-18 |
Armark Authentication Technologies, Llc |
Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
|
|
US8574289B2
(en)
|
2009-02-09 |
2013-11-05 |
St. Jude Medical, Cardiology Division, Inc. |
Inflatable minimally invasive system for delivering and securing an annular implant
|
|
CN106946812B
(zh)
|
2009-02-09 |
2020-10-09 |
伊利诺伊大学评议会 |
作为个性化抗癌药的胱天蛋白酶原活化化合物的设计、合成和评价
|
|
CN102481269B
(zh)
|
2009-05-11 |
2015-10-07 |
博格有限责任公司 |
包含辅酶q10的药物组合物及其制备方法
|
|
AU2009347159B2
(en)
|
2009-05-27 |
2015-09-03 |
Cephalon, Inc. |
Combination therapy for the treatment of multiple myeloma
|
|
WO2010151746A2
(en)
|
2009-06-26 |
2010-12-29 |
Armark Authentication Technologies, Llc |
Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
|
|
TWI386203B
(zh)
|
2011-01-07 |
2013-02-21 |
Univ China Medical |
治療腦癌或用以降低腦癌細胞對替莫唑胺之抗藥性之醫藥組合物及其應用
|
|
WO2012118978A1
(en)
|
2011-03-03 |
2012-09-07 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treating oncovirus positive cancers
|
|
US20140348819A1
(en)
|
2011-06-24 |
2014-11-27 |
Dana-Farber Cancer Institute, Inc. |
Methods of Treating Cancer
|
|
DK3686193T3
(da)
*
|
2011-07-27 |
2022-05-30 |
Astrazeneca Ab |
2-(2,4,5-substitueret anilino)pyrimidinforbindelser
|
|
US8916705B2
(en)
|
2011-10-14 |
2014-12-23 |
The Board of Trustees of The University of Illilnois |
Procaspase-activating compounds and compositions
|
|
EP2819661B1
(en)
|
2012-03-02 |
2016-11-09 |
The Board of Trustees of the University of Illionis |
Potent anticancer activity via dual compound activation
|
|
US9399035B2
(en)
|
2012-03-06 |
2016-07-26 |
The Board Of Trustees Of The University Of Illinois |
Procaspase 3 activation by combination therapy
|
|
DK3290035T3
(da)
|
2012-03-06 |
2019-08-05 |
Univ Illinois |
Procaspase-kombinationsterapi til behandling af cancer
|
|
CA2879798C
(en)
|
2012-08-03 |
2022-05-31 |
The Board Of Trustees Of The University Of Illinois |
Procaspase enzyme-activating substituted 2-(4-benzylpiperazin-1-yl)-n'-(2-hydroxybenzylidene)acetohydrazide derivatives and compostions thereof
|
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
|
CN105163584B
(zh)
|
2013-03-05 |
2019-06-04 |
田纳西大学研究基金会 |
用于治疗癌症的化合物
|
|
WO2014193898A1
(en)
|
2013-05-31 |
2014-12-04 |
Merck Sharp & Dohme Corp. |
Combination therapies for cancer
|
|
TWI839690B
(zh)
|
2013-07-12 |
2024-04-21 |
印度商皮拉馬爾企業有限公司 |
治療黑色素瘤的藥物組合的用途
|
|
GB201320302D0
(en)
*
|
2013-11-18 |
2014-01-01 |
Element Six Ltd |
Diamond components for quantum imaging sensing and information processing devices
|
|
JP7033451B2
(ja)
*
|
2015-06-05 |
2022-03-10 |
ザ ボード オブ トラスティーズ オブ ザ ユニバーシテイ オブ イリノイ |
Pac-1併用療法
|
|
BR112018012255A2
(pt)
|
2015-12-18 |
2018-12-04 |
Ignyta Inc |
método para tratar câncer
|
|
US11932870B2
(en)
|
2016-12-05 |
2024-03-19 |
Fate Therapeutics, Inc. |
Compositions and methods for immune cell modulation in adoptive immunotherapies
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
CA3082575A1
(en)
*
|
2017-11-17 |
2019-05-23 |
The Board Of Trustees Of The University Of Illinois |
Cancer therapy by degrading dual mek signaling
|